Disclaimer: NxStage has prepared this as a tool as supplemental to your hospital emergency preparedness plans. This is not a complete and comprehensive checklist. This is for informational purposes only.
INDICATIONS FOR USE: The NxStage® System One™ is indicated for the treatment of acute and chronic renal failure, or fluid overload using hemofiltration, hemodialysis, and/or ultrafiltration, in an acute or chronic care facility. The NxStage System One is also indicated for Therapeutic Plasma Exchange in a clinical environment. All treatments must be administered under a physician’s prescription and must be observed by a trained and qualified person, considered to be competent in the use of this device by the prescribing physician. NxView™ is a computer-based touch screen user interface that provides online instructions for use, summarized system information, and remote access. NxView is contraindicated as the sole method of monitoring a patient during treatment.
RISK INFORMATION: Kidney replacement therapy, as with any medical therapy, is not without risks. The decision of which therapy to use should be made by the physician, based on previous experience and on the individual facts and circumstances of the patient. There is no literature demonstrating one therapy is clinically better than another.
© 2022 Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, NxStage, System One, and NxView are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners. P/N 105166-02 Rev A 08/2022, APM4440 Rev A
